Evidence map›Paper›PMID 42905042›Full record

ArticleOral health & preventive dentistry2026

Immune-related Plasma Proteins Associated with Recurrent Aphthous Stomatitis Identified by Mendelian Randomization and Clinical Validation.

Yongkang Wang, Jian Che, Cuiqiang Guan, Hongbo Guo

Abstract read
In one paragraph

Article in Oral health & preventive dentistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yongkang Wang
Jian Che
Cuiqiang Guan
Hongbo Guo

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo identify immune-related plasma proteins causally associated with susceptibility to recurrent aphthous stomatitis (RAS) through two-sample Mendelian randomization, and to validate their biological and clinical relevance using integrative multi-omics analyses and clinical samples. MATERIALS AND

methodsTwo-sample Mendelian randomization was performed using protein quantitative trait locus (pQTL) data for immune-related plasma proteins from the deCODE genetics database and genome-wide association study (GWAS) summary statistics for RAS to identify proteins with potential causal associations. Candidate proteins were further evaluated by Gene Ontology (GO)/Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment, protein-protein interaction (PPI) network, summary-data-based Mendelian randomization (SMR), and colocalization analyses. Single-cell transcriptomic data from oral mucosa were integrated to characterize the cellular expression patterns of the corresponding genes. Finally, plasma levels of the candidate proteins were measured by enzyme-linked immunosorbent assay (ELISA) in 35 patients with RAS (sampled during both the ulcerative and healing phases) and 35 healthy controls to validate their clinical relevance.

resultsA total of 28 immune-related plasma proteins were identified as having potential causal associations with RAS through two-sample Mendelian randomization. Functional enrichment analysis indicated that these proteins were mainly involved in immune and inflammatory pathways, including natural killer (NK) cell-mediated cytotoxicity, Th1/Th2 cell differentiation, and the IL-17 signaling pathway. SMR and colocalization analyses highlighted IL17A, MMP1, and IL2RA as key candidate genes, with IL17A showing the strongest genetic evidence. Single-cell transcriptomic analysis further revealed distinct cell-type-specific expression patterns of these genes in the oral mucosa. Clinical validation confirmed statistically significant alterations in the plasma levels of IL17A, MMP1, and IL2RA across different stages of RAS.

conclusionsThis integrative study combining genetic analysis, single-cell transcriptomics, and clinical validation identified IL17A, MMP1, and IL2RA as key immune-related molecules associated with RAS. Among them, IL17A showed the strongest genetic evidence and may serve as a promising biomarker and potential therapeutic target for RAS.

Indexed as

Blood ProteinsMendelian Randomization AnalysisStomatitis, AphthousEnzyme-Linked Immunosorbent AssayFemaleGenome-Wide Association StudyHumansRecurrenceBlood Proteinsimmune-related plasma proteinsMendelian Randomizationrecurrent aphthous stomatitissingle-cell RNA sequencing

Identifiers

PMID42905042
PMCPMC13687939

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.